These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36471789)

  • 1. Modulation of heme and tumor vascular oxygenation- a novel strategy for lung cancer therapy.
    Ghosh P; Mason RP; Liu L; Zhang L
    Oncoscience; 2022; 9():66-69. PubMed ID: 36471789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen-Enhanced Optoacoustic Tomography Reveals the Effectiveness of Targeting Heme and Oxidative Phosphorylation at Normalizing Tumor Vascular Oxygenation.
    Ghosh P; Guo Y; Ashrafi A; Chen J; Dey S; Zhong S; Liu J; Campbell J; Konduri PC; Gerberich J; Garrossian M; Mason RP; Zhang L; Liu L
    Cancer Res; 2020 Sep; 80(17):3542-3555. PubMed ID: 32546631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Changes in Cancer Treatment-Seeing Is Believing.
    Tomaszewski MR
    Cancer Res; 2020 Sep; 80(17):3461-3462. PubMed ID: 32878865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular-immuno-phenotypic (VIP) model for locally advanced and oligo-metastatic cancer: A hypothesis.
    Swamy K
    Med Hypotheses; 2021 Jul; 152():110618. PubMed ID: 34102599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models.
    Tao L; Huang G; Shi S; Chen L
    Med Oncol; 2014 Jan; 31(1):777. PubMed ID: 24271420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor microenvironment in non-small-cell lung cancer.
    Graves EE; Maity A; Le QT
    Semin Radiat Oncol; 2010 Jul; 20(3):156-63. PubMed ID: 20685578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells.
    Sohoni S; Ghosh P; Wang T; Kalainayakan SP; Vidal C; Dey S; Konduri PC; Zhang L
    Cancer Res; 2019 May; 79(10):2511-2525. PubMed ID: 30902795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.
    Dey S; Kumari S; Kalainayakan SP; Campbell J; Ghosh P; Zhou H; FitzGerald KE; Li M; Mason RP; Zhang L; Liu L
    Oncotarget; 2018 Jan; 9(3):4090-4101. PubMed ID: 29423106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of the vasculature for treatment of cancer and other diseases.
    Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
    Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin.
    Baker JH; Kyle AH; Bartels KL; Methot SP; Flanagan EJ; Balbirnie A; Cran JD; Minchinton AI
    PLoS One; 2013; 8(10):e76832. PubMed ID: 24204680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia.
    Glück AA; Orlando E; Leiser D; Poliaková M; Nisa L; Quintin A; Gavini J; Stroka DM; Berezowska S; Bubendorf L; Blaukat A; Aebersold DM; Medová M; Zimmer Y
    Oncogene; 2018 Jul; 37(30):4181-4196. PubMed ID: 29717265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice.
    Xu Z; Dong Y; Peng F; Yu Z; Zuo Y; Dai Z; Chen Y; Wang J; Hu X; Zhou Q; Ma H; Bao Y; Gao G; Chen M
    Cancer Gene Ther; 2015 Mar; 22(4):181-7. PubMed ID: 25591809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.
    Dings RP; Loren M; Heun H; McNiel E; Griffioen AW; Mayo KH; Griffin RJ
    Clin Cancer Res; 2007 Jun; 13(11):3395-402. PubMed ID: 17545548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen Enhanced Optoacoustic Tomography (OE-OT) Reveals Vascular Dynamics in Murine Models of Prostate Cancer.
    Tomaszewski MR; Gonzalez IQ; O'Connor JP; Abeyakoon O; Parker GJ; Williams KJ; Gilbert FJ; Bohndiek SE
    Theranostics; 2017; 7(11):2900-2913. PubMed ID: 28824724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the tumor vasculature and oxygenation to improve therapy.
    Siemann DW; Horsman MR
    Pharmacol Ther; 2015 Sep; 153():107-24. PubMed ID: 26073310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers.
    Horst B; Pradhan S; Chaudhary R; Listik E; Quintero-Macias L; Choi AS; Southard M; Liu Y; Whitaker R; Hempel N; Berchuck A; Nixon AB; Lee NY; Henis YI; Mythreye K
    Commun Biol; 2022 Jun; 5(1):536. PubMed ID: 35654828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy.
    Wu JB; Tang YL; Liang XH
    Onco Targets Ther; 2018; 11():6901-6909. PubMed ID: 30410348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients.
    Gerstner ER; Emblem KE; Yen YF; Dietrich J; Jordan JT; Catana C; Wenchin KL; Hooker JM; Duda DG; Rosen BR; Kalpathy-Cramer J; Jain RK; Batchelor TT
    Neurooncol Adv; 2020; 2(1):vdaa157. PubMed ID: 33392506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
    Viallard C; Larrivée B
    Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.